Clinical Trials Sponsored by GaiaMais

Total 3 results

GamaMabs Pharma

Completed

Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers

Colorectal Cancer

Belgium, Czechia
GamaMabs Pharma

Completed

First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers

Neoplasm, Gynecologic

France, Belgium, United Kingdom
Hospital Israelita Albert Einstein
Emory University; GaiaMais; Instituto Sidarta; Universidade Federal do ABC

Recruiting

Effects of a Four Weeks Social Emotional and Ethical Learning Training in Brazilian Public School Teachers

Social Emotional Learning

Brazil

3

Subscribe